AUSTIN, Texas, Nov. 21, 2014 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that management will be participating in the following investment conferences in New York, NY:
- Brean Capital Life Sciences Summit on Monday, November 24, 2014
- 26th Annual Piper Jaffray Healthcare Conference – Management will be presenting at 2:00 PM Eastern Time on Tuesday, December 2, 2014
The presentation at Piper Jaffray conference will also be broadcast live over the Internet and can be accessed on the Investors section of the Company's website at www.ldr.com. For those who are not available to listen to the live webcast, the presentation will be archived for 90 days on LDR's website.
About LDR Holding Corporation
LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders. LDR's primary products are based on its exclusive Mobi® non-fusion and VerteBRIDGE® fusion technology platforms and are designed for applications in the cervical and lumbar spine. These technologies are designed to enable products that are less invasive, provide greater intra-operative flexibility, offer simplified surgical techniques and promote improved clinical outcomes for patients as compared to existing alternatives. In August 2013, LDR received approval from the U.S. Food and Drug Administration (FDA) for the Mobi-C cervical disc replacement device, the first and only cervical disc replacement device to receive FDA approval to treat both one-level and two-level cervical disc disease. For more information regarding LDR Holding and the Mobi-C Cervical Disc, visit www.ldr.com or www.cervicaldisc.com.